Martin Eklund

Martin Eklund

Auto-generated profile, based on publicly available information

Martin Eklund

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2022 in Nature Medicine
Verified
Journal Article
Open access
PDF file
WBWouter Bulten
Wouter Bulten
KKKimmo Kartasalo
Kimmo Kartasalo
PCPo-Hsuan Cameron Chen
Po-Hsuan Cameron Chen
PSPeter Ström
Peter Ström
HPHans Pinckaers
Hans Pinckaers
MEMartin Eklund
Martin Eklund
Artificial intelligence (AI) has shown promise for diagnosing prostate cancer in biopsies. However, results have been limited to individual studies, lacking validation in multinational settings. Competitions have been shown to be accelerators for medical imaging innovations, but their impact is hindered by lack of reproducibility and independent validation. With this in mind, we organized the PANDA challenge—the largest histopathology competition to date, joined by 1,290 developers—to catalyze development of reproducible AI algorithms for Gleason grading using 10,616 digitized prostate biopsies. We validated that a diverse set of submitted algorithms reached pathologist-level performance on independent cross-continental cohorts, fully blinded to the algorithm developers. On United States and European external validation sets, the algorithms achieved agreements of 0.862 (quadratically weighted κ, 95% confidence interval (CI), 0.840–0.884) and 0.868 (95% CI, 0.835–0.900) with expert uropathologists. Successful generalization across different patient populations, laboratories and reference standards, achieved by a variety of algorithmic approaches, warrants evaluating AI-based Gleason grading in prospective clinical trials.

1 February 2020 in The Lancet Oncology
Verified
Journal Article
Closed access
PSPeter Ström
Peter Ström
KKKimmo Kartasalo
Kimmo Kartasalo
HOHenrik Olsson
Henrik Olsson
LSLeslie Solorzano
Leslie Solorzano
BDBrett Delahunt
Brett Delahunt
MEMartin Eklund
Martin Eklund

4 January 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DCDavid V. Conti
David V. Conti
BDBurcu F. Darst
Burcu F. Darst
LMLilit C. Moss
Lilit C. Moss
ESEdward J. Saunders
Edward J. Saunders
XSXin Sheng
Xin Sheng
CHChristopher A. Haiman
Christopher A. Haiman

9 November 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AWAnqi Wang
Anqi Wang
JSJiayi Shen
Jiayi Shen
ARAlex A. Rodriguez
Alex A. Rodriguez
ESEdward J. Saunders
Edward J. Saunders
FCFei Chen
Fei Chen
CHChristopher A. Haiman
Christopher A. Haiman

1 February 2020 in Radiology
Verified
Journal Article
Closed access
KDKarin Dembrower
Karin Dembrower
YLYue Liu
Yue Liu
HAHossein Azizpour
Hossein Azizpour
MEMartin Eklund
Martin Eklund
KSKevin Smith
Kevin Smith
FSFredrik Strand
Fredrik Strand
A deep neural network trained on mammographic screening images and breast cancer outcome can more accurately predict which women are at risk for future breast cancer than can density-based models, ... Background Most risk prediction models for breast cancer are based on questionnaires and mammographic density assessments. By training a deep neural network, further information in the mammographic...

15 December 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
HOHenrik Olsson
Henrik Olsson
KKKimmo Kartasalo
Kimmo Kartasalo
NMNita Mulliqi
Nita Mulliqi
MCMarco Capuccini
Marco Capuccini
PRPekka Ruusuvuori
Pekka Ruusuvuori
MEMartin Eklund
Martin Eklund
Unreliable predictions can occur when an artificial intelligence (AI) system is presented with data it has not been exposed to during training. We demonstrate the use of conformal prediction to detect unreliable predictions, using histopathological diagnosis and grading of prostate biopsies as example. We digitized 7788 prostate biopsies from 1192 men in the STHLM3 diagnostic study, used for training, and 3059 biopsies from 676 men used for testing. With conformal prediction, 1 in 794 (0.1%) predictions is incorrect for cancer diagnosis (compared to 14 errors [2%] without conformal prediction) while 175 (22%) of the predictions are flagged as unreliable when the AI-system is presented with new data from the same lab and scanner that it was trained on. Conformal prediction could with small samples (N = 49 for external scanner, N = 10 for external lab and scanner, and N = 12 for external lab, scanner and pathology assessment) detect systematic differences in external data leading to worse predictive performance. The AI-system with conformal prediction commits 3 (2%) errors for cancer detection in cases of atypical prostate tissue compared to 44 (25%) without conformal prediction, while the system flags 143 (80%) unreliable predictions. We conclude that conformal prediction can increase patient safety of AI-systems.